Notice Information
Notice Title
cancer gene analysis
Notice Description
The UKSCB requires an external contractor (third party) to perform cancer gene analysis on UKSCB derived EU Tissue and Cellular Directive (EUTCD) compliant human embryonic stem cell (hESC) lines. UKSCB is licenced under the HTA Human Tissue (Quality and Safety for Human Application) Regulations 2018 for the production of starting materials for clinical application. According to HTA regulations any testing activities that are subcontracted to external contractors must be appropriately validated to demonstrate that the testing method is fit for purpose. In addition, the contract testing laboratory has to be accredited by the regulatory body for the licensable activities. It is estimated that the contact will run for at least of three years and will cover testing of approximately 38 hESC lines. The contact should be priced based on the number of cancer genes in the panel and DNA isolation from cell lines. Further communications or meetings can be arranged for additional details on the testing or validation. As part of ongoing UKSCB service provider qualification program the third party might require to fill UKSCB Quality Questionnaire or accommodate on-site audit by UKSCB. For further information and if you believe, you have the capability to do this work, please feel free to contact via email (Nawaz.habib@nibsc.org) before close of play 25 May 2018.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-b5fd17-be8921f1-3465-4dbf-883f-53e71f717872
- Publication Source
- Contracts Finder
- Latest Notice
- https://www.contractsfinder.service.gov.uk/Notice/a4a49282-bf8e-463f-b9f2-d1d8b6e3d03b
- Current Stage
- Planning
- All Stages
- Planning
Procurement Classification
- Notice Type
- Market Engagement Notice
- Procurement Type
- Standard
- Procurement Category
- Not specified
- Procurement Method
- Not Specified
- Procurement Method Details
- Not specified
- Tender Suitability
- SME
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
73 - Research and development services and related consultancy services
-
- CPV Codes
33159000 - Clinical chemistry system
73110000 - Research services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 4 May 20187 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- 25 May 2018Expired
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Planning
- Lots Status
- Not Specified
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- POTTERS BAR,
- Postcode
- EN6 3QG
- Post Town
- Enfield
- Country
- England
-
- Major Region (ITL 1)
- TLH East (England)
- Basic Region (ITL 2)
- TLH2 Bedfordshire and Hertfordshire
- Small Region (ITL 3)
- TLH27 South West Hertfordshire
- Delivery Location
- Not specified
-
- Local Authority
- Hertsmere
- Electoral Ward
- Shenley
- Westminster Constituency
- Hertsmere
Further Information
Notice Documents
-
https://www.contractsfinder.service.gov.uk/Notice/a4a49282-bf8e-463f-b9f2-d1d8b6e3d03b
4th May 2018 - Early engagement notice on Contracts Finder
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-b5fd17-be8921f1-3465-4dbf-883f-53e71f717872-2018-05-04T16:43:29+01:00",
"date": "2018-05-04T16:43:29+01:00",
"ocid": "ocds-b5fd17-be8921f1-3465-4dbf-883f-53e71f717872",
"language": "en",
"initiationType": "tender",
"title": "cancer gene analysis",
"planning": {
"milestones": [
{
"id": "1",
"title": "Engagement end date",
"type": "engagement",
"dueDate": "2018-05-25T23:59:59+01:00"
}
],
"documents": [
{
"id": "1",
"documentType": "marketEngagementNotice",
"description": "Early engagement notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/a4a49282-bf8e-463f-b9f2-d1d8b6e3d03b",
"datePublished": "2018-05-04T16:43:29+01:00",
"format": "text/html",
"language": "en"
}
]
},
"tender": {
"id": "cancer gene analysis - UKSCB",
"title": "cancer gene analysis",
"description": "The UKSCB requires an external contractor (third party) to perform cancer gene analysis on UKSCB derived EU Tissue and Cellular Directive (EUTCD) compliant human embryonic stem cell (hESC) lines. UKSCB is licenced under the HTA Human Tissue (Quality and Safety for Human Application) Regulations 2018 for the production of starting materials for clinical application. According to HTA regulations any testing activities that are subcontracted to external contractors must be appropriately validated to demonstrate that the testing method is fit for purpose. In addition, the contract testing laboratory has to be accredited by the regulatory body for the licensable activities. It is estimated that the contact will run for at least of three years and will cover testing of approximately 38 hESC lines. The contact should be priced based on the number of cancer genes in the panel and DNA isolation from cell lines. Further communications or meetings can be arranged for additional details on the testing or validation. As part of ongoing UKSCB service provider qualification program the third party might require to fill UKSCB Quality Questionnaire or accommodate on-site audit by UKSCB. For further information and if you believe, you have the capability to do this work, please feel free to contact via email (Nawaz.habib@nibsc.org) before close of play 25 May 2018.",
"status": "planning",
"classification": {
"scheme": "CPV",
"id": "33159000",
"description": "Clinical chemistry system"
},
"additionalClassifications": [
{
"scheme": "CPV",
"id": "73110000",
"description": "Research services"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"postalCode": "EN6 3QG"
}
]
}
],
"suitability": {
"sme": true,
"vcse": false
}
},
"parties": [
{
"id": "GB-GOR-EA63",
"name": "Medicines and Healthcare Products Regulatory Agency",
"identifier": {
"legalName": "Medicines and Healthcare Products Regulatory Agency",
"scheme": "GB-GOR",
"id": "EA63"
},
"address": {
"streetAddress": "NIBSC, Blanche Lane,, South Mimms,",
"locality": "Potters Bar,",
"postalCode": "EN6 3QG",
"countryName": "England"
},
"contactPoint": {
"name": "Nawaz Habib",
"email": "nawaz.habib@nibsc.org",
"telephone": "01707641212"
},
"roles": [
"buyer"
]
}
],
"buyer": {
"id": "GB-GOR-EA63",
"name": "Medicines and Healthcare Products Regulatory Agency"
}
}